Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

1.980 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
IOVA COURT NEWS: Iovance Biotherapeutics, Inc. Was Sued for Securities Fraud - Investors Are Urged to Contact BFA Law By July 14 Legal Deadline
Via ACCESS Newswire
Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure - Hagens Berman
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
Via ACCESS Newswire
IOVA COURT NOTICE: Lose Money on Iovance Biotherapeutics, Inc.? Contact BFA Law before Upcoming Class Action Deadline
Via ACCESS Newswire
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox Before July 14, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Iovance Biotherapeutics, Inc. (IOVA) - Contact Kaplan Fox Before July 14, 2025
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
From Pomerantz LLP
Via GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
From Kahn Swick & Foti, LLC
Via GlobeNewswire
Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks And Legal Pressure - Hagens Berman
Via ACCESS Newswire
IOVA NOTIFICATION: Iovance Biotherapeutics, Inc. Shareholders are Notified of The Ongoing Securities Fraud Class Action Lawsuit - Contact BFA Law by July 14
Via ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
IOVA SHAREHOLDER ALERT: BFA Law Reminds Iovance Biotherapeutics, Inc. Investors of Upcoming July 14 Class Action Deadline - Contact the Firm if You Suffered Losses
Via ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
From Pomerantz LLP
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA
From The Rosen Law Firm PA
Via GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
From SkyMedia, LLC
Via GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
From Kahn Swick & Foti, LLC
Via GlobeNewswire
Investors of Iovance Biotherapeutics, Inc. (IOVA) Have Until July 14, 2025 To Seek a Leadership Role In The Class Action Lawsuit - Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Investors of Iovance Biotherapeutics, Inc. (IOVA) Have Until July 14, 2025 To Seek a Leadership Role In The Class Action Lawsuit - Contact Kaplan Fox
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
From Pomerantz LLP
Via GlobeNewswire
Iovance Biotherapeutics to Present at Upcoming Conference
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Iovance Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - IOVA
From Pomerantz LLP
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IOVA
From The Rosen Law Firm PA
Via GlobeNewswire
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
From SkyMedia, LLC
Via GlobeNewswire
IOVANCE BIOTHERAPEUTICS DEADLINE IS JULY 14, 2025 - Investors are Encouraged to Contact Kaplan Fox
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
IOVANCE BIOTHERAPEUTICS DEADLINE IS JULY 14, 2025 - Investors are Encouraged to Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
IOVANCE BIOTHERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Iovance Biotherapeutics, Inc. - IOVA
From Kahn Swick & Foti, LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.